OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial
Andrei C. Spósito, Íkaro Breder, Joaquim Barreto, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Andrei C. Spósito, Íkaro Breder, Joaquim Barreto, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Showing 14 citing articles:
The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7
Wujun Chen, Xiaolin Wu, Jianxia Hu, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Wujun Chen, Xiaolin Wu, Jianxia Hu, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy
Emrush Rexhaj, Sarah Bär, Rodrigo Soria, et al.
Atherosclerosis (2024) Vol. 392, pp. 117504-117504
Open Access | Times Cited: 9
Emrush Rexhaj, Sarah Bär, Rodrigo Soria, et al.
Atherosclerosis (2024) Vol. 392, pp. 117504-117504
Open Access | Times Cited: 9
The role of PCSK9 in heart failure and other cardiovascular diseases—mechanisms of action beyond its effect on LDL cholesterol
Mieczysław Dutka, Karolina Zimmer, Michał Ćwiertnia, et al.
Heart Failure Reviews (2024) Vol. 29, Iss. 5, pp. 917-937
Open Access | Times Cited: 9
Mieczysław Dutka, Karolina Zimmer, Michał Ćwiertnia, et al.
Heart Failure Reviews (2024) Vol. 29, Iss. 5, pp. 917-937
Open Access | Times Cited: 9
The effect of sodium-glucose co-transporter-2 inhibitors on markers of subclinical atherosclerosis
Panagiotis Stachteas, Paschalis Karakasis, Dimitrios Patoulias, et al.
Annals of Medicine (2023) Vol. 55, Iss. 2
Open Access | Times Cited: 16
Panagiotis Stachteas, Paschalis Karakasis, Dimitrios Patoulias, et al.
Annals of Medicine (2023) Vol. 55, Iss. 2
Open Access | Times Cited: 16
Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial
Isabella Bonilha, Érica Ivana Lázaro Gomes, Helison Rafael Pereira do Carmo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4108-4108
Open Access | Times Cited: 2
Isabella Bonilha, Érica Ivana Lázaro Gomes, Helison Rafael Pereira do Carmo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4108-4108
Open Access | Times Cited: 2
Increase of PCSK9 expression in diabetes promotes VEGFR2 ubiquitination to inhibit endothelial function and skin wound healing
Jianjun Gao, Fang-Yuan Wu, Yujia Liu, et al.
Science China Life Sciences (2024)
Closed Access | Times Cited: 2
Jianjun Gao, Fang-Yuan Wu, Yujia Liu, et al.
Science China Life Sciences (2024)
Closed Access | Times Cited: 2
A Comprehensive Review of Clinical Studies Applying Flow-Mediated Dilation
Yuran Ahn, Nay Aung, Hyo–Suk Ahn
Diagnostics (2024) Vol. 14, Iss. 22, pp. 2499-2499
Open Access | Times Cited: 2
Yuran Ahn, Nay Aung, Hyo–Suk Ahn
Diagnostics (2024) Vol. 14, Iss. 22, pp. 2499-2499
Open Access | Times Cited: 2
Lack of impact of ipragliflozin on endothelial function in patients with type 2 diabetes: sub-analysis of the PROTECT study
Shinji Kishimoto, Yukihito Higashi, Takumi Imai, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Shinji Kishimoto, Yukihito Higashi, Takumi Imai, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 4
The Anti-Thrombotic Effects of PCSK9 Inhibitors
Martin Jozef Péč, J Benko, Jakub Jurica, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1197-1197
Open Access | Times Cited: 4
Martin Jozef Péč, J Benko, Jakub Jurica, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1197-1197
Open Access | Times Cited: 4
Protective effect of evolocumab on Müller cells in the rat retina under hyperglycaemic and hypoxic conditions
Qing Zhou, Huan Tang, Shuting Li
Journal of Diabetes and its Complications (2023) Vol. 37, Iss. 10, pp. 108593-108593
Closed Access | Times Cited: 4
Qing Zhou, Huan Tang, Shuting Li
Journal of Diabetes and its Complications (2023) Vol. 37, Iss. 10, pp. 108593-108593
Closed Access | Times Cited: 4
Estimating the effect of lipid‐lowering agents on novel subtypes of adult‐onset diabetes
Jianan Ye, Keyu Guo, Jiaqi Li, et al.
Diabetes/Metabolism Research and Reviews (2024) Vol. 40, Iss. 4
Closed Access | Times Cited: 1
Jianan Ye, Keyu Guo, Jiaqi Li, et al.
Diabetes/Metabolism Research and Reviews (2024) Vol. 40, Iss. 4
Closed Access | Times Cited: 1
Insight into the role of PCSK9 in glucose metabolism
Jia-ni Xu, Tingting Wang, Hong Shu, et al.
Clinica Chimica Acta (2023) Vol. 547, pp. 117444-117444
Open Access | Times Cited: 2
Jia-ni Xu, Tingting Wang, Hong Shu, et al.
Clinica Chimica Acta (2023) Vol. 547, pp. 117444-117444
Open Access | Times Cited: 2
The effect of empagliflozin on circulating endothelial progenitor cells in patients with diabetes and stable coronary artery disease
Roy Hershenson, Inbar Nardi Agmon, Dorit Leshem‐Lev, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access
Roy Hershenson, Inbar Nardi Agmon, Dorit Leshem‐Lev, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access
PCSK-9-inhibitor therapy improves endothelial function in high-risk patients with cardiovascular disease
Dennis Kannenkeril, Agnes Bosch, Julie Kolwelter, et al.
Clinical Research in Cardiology (2024)
Open Access
Dennis Kannenkeril, Agnes Bosch, Julie Kolwelter, et al.
Clinical Research in Cardiology (2024)
Open Access
